Sanofi And Regeneron Initiate 400-Patient Coronavirus Trial With Kevzara

 
• By Jessica Merrill

The Phase II/III trial will begin enrolling patients in the US immediately, with Regeneron taking the lead in US development and Sanofi leading ex-US trials. 

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
There is early evidence IL-6 drugs help drive down inflammatory immune response

More from Clinical Trials

More from R&D